UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027560 |
|---|---|
| Receipt number | R000031594 |
| Scientific Title | A study to evaluate the safety of excessive ingestion of seaweed extract containing foods for healthy adults. |
| Date of disclosure of the study information | 2018/08/06 |
| Last modified on | 2017/11/30 18:11:16 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study to evaluate the safety of excessive ingestion of seaweed extract containing foods for healthy adults.
Acronym
A study to evaluate the safety of excessive ingestion of seaweed extract containing foods.
Scientific Title
A study to evaluate the safety of excessive ingestion of seaweed extract containing foods for healthy adults.
Scientific Title:Acronym
A study to evaluate the safety of excessive ingestion of seaweed extract containing foods.
Region
| Japan |
Condition
Condition
None
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety of excessive ingestion of seaweed extract containing foods for 4 weeks.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Hematologic test
Blood biochemistry test
Urine analysis
Blood pressure/pulsation
Weight
Doctor's questions
Adverse event
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingestion of seaweed extract containing foods (30 tablets per day, 4 weeks)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Healthy males and females aged 20-64 years.
Key exclusion criteria
(1) Subjects who use health food containing large amount of seaweed extract.
(2) Subjects who has a disease under treatment.
(3) Subjects who has under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, heart disease or cancer).
(4) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination.
(5) Subjects who have habits affecting research results, such as doing shift work day and night, or Subjects who have a plan that affect research results such as day and night shift work and overseas.
(6) Subjects who have participated in other clinical study within the last one month prior to the current study.
(7) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
(8) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire.
(9) Subjects who are judged as unsuitable by doctor for other reasons.
Target sample size
11
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Keiichiro Inafuku |
Organization
KANEHIDE BIO Co., Ltd.
Division name
Research and development department
Zip code
Address
5-2-2, Nishizakicho, Itoman, Okinawa
TEL
098-994-1048
k-ina.hk@kanehide.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Saki Fukuchi |
Organization
TTC Co.,Ltd
Division name
Clinical Research Planning Department
Zip code
Address
Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo
TEL
03-5459-5329
Homepage URL
s.fukuchi@ttc-tokyo.co.jp
Sponsor or person
Institute
TTC Co.,Ltd
Institute
Department
Personal name
Funding Source
Organization
KANEHIDE BIO Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 08 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 05 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 06 | Month | 05 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 05 | Month | 31 | Day |
Last modified on
| 2017 | Year | 11 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031594
